A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1–CDK4 interaction
Jialiang Zhao(Jilin University), Guiying Li(Jilin University), Fang Yang(Planetary Science Institute), Xinze Yu(Jilin University), Ziyang Gao(Jilin University), Cheng Cheng(Jilin University), Tong Zhang(Pacific Northwest National Laboratory), Yan Wu(Binzhou Medical University), Siyuan Hu(Beijing Normal University), Tong Xiao(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ze Ren(Jilin University)
Cited by 5
Related Papers
Emerging contaminants: A One Health perspective
|The Innovation|2024|497
Heritability of the Specific Cognitive Ability of Face Perception
|Current Biology|2010|243
<i>TP53</i> Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children
|Journal of Clinical Oncology|2018|179
New Frontiers in Osteoporosis Therapy
|Annual Review of Medicine|2019|141
Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy
|British Journal of Haematology|2021|122